Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5,129,000 | 5,011,000 | 5,985,000 | 4,671,461 | 6,113,043 |
| Income taxes - deferred | -1,512,000 | -1,169,000 | -1,473,000 | -1,478,050 | -2,463,250 |
| Accounts receivable | -82,000 | -429,000 | -309,000 | -60,357 | -240,945 |
| Accounts payable and accrued liabilities | 28,000 | -336,000 | N/A | N/A | N/A |
| Other Working Capital | -277,000 | -847,000 | -1,000 | -812,756 | -1,006,212 |
| Other Operating Activity | 6,473,000 | 6,285,000 | 4,321,000 | 4,796,975 | 4,201,391 |
| Operating Cash Flow | $9,759,000 | $8,515,000 | $8,523,000 | $7,117,273 | $6,604,026 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,442,000 | -1,700,000 | -1,483,000 | -1,283,263 | -280,345 |
| Net Acquisitions | -1,659,000 | -5,563,000 | -661,000 | N/A | N/A |
| Purchase Of Investment | -74,000 | -5,000 | -6,000 | -436,213 | -512,956 |
| Other Investing Activity | -208,000 | -19,000 | -4,000 | 686 | 3,031 |
| Investing Cash Flow | $-3,383,000 | $-7,287,000 | $-2,154,000 | $-1,718,790 | $-790,271 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 310,000 | -785,000 | 557,000 | N/A | N/A |
| Debt Issued | 505,000 | 4,697,000 | 765,000 | N/A | N/A |
| Debt Repayment | -1,981,000 | -1,989,000 | -1,253,000 | N/A | N/A |
| Common Stock Issued | 75,000 | 168,000 | 57,000 | 294,924 | 356,872 |
| Common Stock Repurchased | -321,000 | 0 | -1,227,000 | -1,808,639 | N/A |
| Dividend Paid | -3,138,000 | -2,878,000 | -2,708,000 | -2,367,623 | -2,041,975 |
| Other Financing Activity | -97,000 | 0 | 0 | -946,501 | -4,168,810 |
| Financing Cash Flow | $-4,647,000 | $-787,000 | $-3,809,000 | $-4,827,839 | $-5,853,913 |
| Exchange Rate Effect | 44,000 | 25,000 | -45,000 | -12,346 | -56,069 |
| Beginning Cash Position | 4,692,000 | 4,226,000 | 1,711,000 | 1,155,005 | 1,248,673 |
| End Cash Position | 6,465,000 | 4,692,000 | 4,226,000 | 1,713,989 | 1,153,204 |
| Net Cash Flow | $1,729,000 | $441,000 | $2,560,000 | $570,644 | $-40,158 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,759,000 | 8,515,000 | 8,523,000 | 7,117,273 | 6,604,026 |
| Capital Expenditure | -1,573,000 | -1,785,000 | -1,606,000 | -1,612,480 | -1,454,007 |
| Free Cash Flow | 8,186,000 | 6,730,000 | 6,917,000 | 5,504,793 | 5,150,019 |